Health Technology Assessment for Decision Making in Latin America: Good Practice Principles

Pichón-Riviere, Andrés; Soto, Natalie; Augustovski, Federico; Martí, Sebastián García; Sampietro-Colom, Laura

doi:10.1017/s0266462318000326

Cited by 23 publications

(28 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For example, in Latin America, the need for transparency in the production of HTA, involvement of relevant stakeholders in the process, mechanisms to appeal decisions, clear prioritysetting processes, and a clear link between HTA and decisionmaking have recently been emphasized. 24,25 In addition, HTA agencies in Asia recently expressed their need to improve transparency and accountability throughout the process. For example, it was recommended by the HTAi Asia Policy Forum members that a standardized, transparent methodology for priority-setting regarding coverage decision-making needs to be developed.…”

Section: Alignment With Other Study Findingsmentioning

confidence: 99%

Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe

Oortwijn¹,

Jansen²,

Baltussen³

2019

Int J Health Policy Manag

View full text Add to dashboard Cite

Background: Evidence-informed deliberative processes (EDPs) were recently introduced to guide health technology assessment (HTA) agencies to improve their processes towards more legitimate decision-making. The EDP framework provides guidance that covers the HTA process, ie, contextual factors, installation of an appraisal committee, selecting health technologies and criteria, assessment, appraisal, and communication and appeal. The aims of this study were to identify the level of use of EDPs by HTA agencies, identify their needs for guidance, and to learn about best practices. Methods: A questionnaire for an online survey was developed based on the EDP framework, consisting of elements that reflect each part of the framework. The survey was sent to members of the International Network of Agencies for Health Technology Assessment (INAHTA). Two weeks following the invitation, a reminder was sent. The data collection took place between September-December 2018. Results: Contact persons from 27 member agencies filled out the survey (response rate: 54%), of which 25 completed all questions. We found that contextual factors to support HTA development and the critical elements regarding conducting and reporting on HTA are overall in place. Respondents indicated that guidance was needed for specific elements related to selecting technologies and criteria, appraisal, and communication and appeal. With regard to best practices, the Canadian Agency for Drugs and Technologies and the National Institute for Health and Care Excellence (NICE, UK) were most often mentioned. Conclusion: This is the first survey among HTA agencies regarding the use of EDPs and provides useful information for further developing a practical guide for HTA agencies around the globe. The results could support HTA agencies in improving their processes towards more legitimate decision-making, as they could serve as a baseline measurement for future monitoring and evaluation.

show abstract

Section: Alignment With Other Study Findingsmentioning

confidence: 99%

Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe

Oortwijn¹,

Jansen²,

Baltussen³

2019

Int J Health Policy Manag

View full text Add to dashboard Cite

show abstract

“…Health policy-makers and professionals increasingly insist on good evidence to support decisions about the development, adoption, acquisition, appropriateness, utilisation, pricing, procurement and reimbursement of health technologies. 20 The development and expanding use of HTAs in the public and private sectors in developed economies and recently in low to middle-income countries [21][22][23][24][25][26][27] reflect this insistence. In particular, the study of the HTA of CIs has gained prominence in recent years.…”

Section: Introductionmentioning

confidence: 99%

Methods for the health technology assessment of complex interventions: a protocol for a scoping review

et al. 2020

View full text Add to dashboard Cite

IntroductionIn healthcare policy and economic literature, research on the health technology assessment (HTA) of complex interventions (CIs) is becoming increasingly important. In many developed countries, HTA guides decision-making to help achieve greater value for money when funding health care. However, research has yet to identify the forms of evidence and evaluation criteria that should be used in the HTA of CIs. Previous research has established that the HTA of CIs requires multiple factors to be evaluated but there is no agreement on which factors ought always to be considered. There is equally little agreement on which forms of evidence ought to be collected or synthesised and how. We plan to perform a systematic scoping review in order to identify the range of evaluation criteria and types of evidence currently used in the HTA of CIs.Method and analysisThis protocol was developed to guide the methodological framework for the conduct of a scoping review on health technology assessment (HTA) of complex interventions (CIs), using the Joanna Briggs Institute guidelines and the six-stage framework proposed by Arksey and O’Malley, in addition to more recent innovations in scoping review methodology. A grey literature search will supplement the primary searches of seven electronic databases for studies available in English between January 2000 and August 2020. Two reviewers will independently screen all search results for inclusion and data will be extracted using a customised data extraction or charting form. Any dispute will be resolved by consensus or through arbitration by a third author. The mnemonic Population, Concept and Context will be adopted to establish criteria for selecting relevant literature, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses: Extension for Scoping Review will be used for reporting the results. Several explanatory-descriptive methods will be used for analysing the extracted data including frequency and trend analyses as well as reflexive thematic coding and analysis.Mapping evidence on the HTA of CIs will allow us to gain a better understanding of both established and emerging practices, including the information types, requirements, values and parameters that are incorporated in the HTA of CIs. We also expect the findings of the scoping review to help identify research gaps that will guide future studies. As healthcare becomes more complex in its delivery, it is timely to determine how these complex interventions should be assessed so that policy decisions can be made about whether implementation and public funding is warranted.Ethics and DisseminationThis scoping review will involve secondary analysis of already collected data, and thus, does not require ethics approval. The research findings will be submitted to peer-reviewed journals for publication and will also be disseminated at conferences and seminars.

show abstract

“…En el primer Foro Latino Americano de Políticas en ETESA de HTAi, realizado en Costa Rica en el año 2016, se discutió sobre los principios de buena práctica que debían guiar la ETESA en la región. Dentro de los principios identificado por los países como más prioritarios se encontraron la transparencia en la realización de ETESA, el involucramiento de actores relevantes (tema discutido en el segundo Foro realizado en Lima, Perú en 2017)(12), la existencia de mecanismos claros para el establecimiento de prioridades, la existencia de mecanismos de apelación y la existencia de un vínculo claro entre la evaluación y la toma de decisión (13). Estos motivos influyeron en la selección del tópico para este tercer Foro de ETESA en Latino América para el año 2018, ya que la utilización de matrices de valor es postulada como una estrategia para favorecer la aplicación de estos principios, así como para promover la transparencia en el proceso de evaluación de tecnologías sanitarias, facilitando de esta manera la participación de distintos actores a lo largo del proceso incluyendo pacientes, profesionales de la salud y productores de la tecnología entre otros.…”

Section: Introductionunclassified

Definiendo el valor de las tecnologías sanitarias en Latino-América: desarrollo de marcos de valor para informar la priorización de recursos sanitarios

Pichón-Riviere

García-Martí

Oortwijn

et al. 2019

Int J Technol Assess Health Care

Self Cite

View full text Add to dashboard Cite

ResumenObjetivosEl reciente desarrollo de marcos de valor responde a una demanda por hacer más explícito e inclusivo el proceso de toma de decisiones sobre asignación de recursos sanitarios. El objetivo del Foro de Políticas en Latino América 2018 de Health Technology Assessment International fue explorar las experiencias internacionales y discutir la potencial aplicación de marcos de valor en la región.MétodosEste manuscrito está basado en un documento base y en las presentaciones y discusiones mantenidas por los miembros del Foro (43 participantes, 12 países) durante el Foro del 2018.ResultadosLos participantes coincidieron en que un proceso de evaluación y toma de decisión basado en marcos de valor más inclusivos y abarcativos podría mejorar la efectividad, eficiencia, sustentabilidad y equidad; promover la transparencia y una evaluación más completa de las tecnologías, mejorar la rendición de cuentas de las decisiones y la participación de actores. Se identificaron como criterios esenciales para ser incluidos en marcos de valor en la región a la carga de enfermedad y severidad de la condición, la efectividad y seguridad de la tecnología, la calidad de la evidencia, la costo-efectividad e impacto presupuestario. Los potenciales desafíos para su implementación identificados incluyeron la escasez de recursos humanos y las demoras en el proceso de evaluación que se podrían producir.ConclusionesLos participantes remarcaron que los próximos pasos deberían ser identificar procesos y metodologías apropiadas, adaptadas al contexto de cada país, para facilitar la aplicación de marcos de valor y mejorar el vínculo entre la evaluación y la toma de decisiones.

show abstract

Health Technology Assessment for Decision Making in Latin America: Good Practice Principles

Cited by 23 publications

References 14 publications

Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe

Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe

Methods for the health technology assessment of complex interventions: a protocol for a scoping review

Definiendo el valor de las tecnologías sanitarias en Latino-América: desarrollo de marcos de valor para informar la priorización de recursos sanitarios

Contact Info

Product

Resources

About